Consistent with this possibility, a CUA to CUG mutation in p53 was identified in a lymphocytic leukemia patient where mutant p53 was found to impair Mdm2-mediated enhancement of p53 translation [137]. This evidence concerns the gene TP53 and lymphoid leukemia.